ATE523511T1 - Pyrazolopyrrolidine als inhibitoren von gamma- sekretase - Google Patents

Pyrazolopyrrolidine als inhibitoren von gamma- sekretase

Info

Publication number
ATE523511T1
ATE523511T1 AT08756023T AT08756023T ATE523511T1 AT E523511 T1 ATE523511 T1 AT E523511T1 AT 08756023 T AT08756023 T AT 08756023T AT 08756023 T AT08756023 T AT 08756023T AT E523511 T1 ATE523511 T1 AT E523511T1
Authority
AT
Austria
Prior art keywords
pyrazolopyrrolidines
inhibitors
gamma secretase
secretase
gamma
Prior art date
Application number
AT08756023T
Other languages
English (en)
Inventor
Darren Dressen
Simeon Bowers
Albert Garofalo
Roy Hom
Matthew Mattson
Original Assignee
Elan Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc filed Critical Elan Pharm Inc
Application granted granted Critical
Publication of ATE523511T1 publication Critical patent/ATE523511T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08756023T 2007-05-25 2008-05-21 Pyrazolopyrrolidine als inhibitoren von gamma- sekretase ATE523511T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93184007P 2007-05-25 2007-05-25
PCT/US2008/064324 WO2008147800A1 (en) 2007-05-25 2008-05-21 Pyrazolopyrrolidines as inhibitors of gamma secretase

Publications (1)

Publication Number Publication Date
ATE523511T1 true ATE523511T1 (de) 2011-09-15

Family

ID=39679310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08756023T ATE523511T1 (de) 2007-05-25 2008-05-21 Pyrazolopyrrolidine als inhibitoren von gamma- sekretase

Country Status (17)

Country Link
US (1) US7977368B2 (de)
EP (1) EP2152713B1 (de)
JP (1) JP2010528036A (de)
AR (1) AR066712A1 (de)
AT (1) ATE523511T1 (de)
AU (1) AU2008256940A1 (de)
BR (1) BRPI0812014A2 (de)
CA (1) CA2687765A1 (de)
CL (1) CL2008001516A1 (de)
CO (1) CO6241122A2 (de)
ES (1) ES2373253T3 (de)
MX (1) MX2009012525A (de)
NZ (1) NZ582039A (de)
PE (1) PE20090280A1 (de)
TW (1) TW200904413A (de)
WO (1) WO2008147800A1 (de)
ZA (1) ZA200908919B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012502051A (ja) * 2008-09-05 2012-01-26 エラン ファーマシューティカルズ，インコーポレイテッド Ｎ−スルホンアミドポリシクル酸ピラゾリル化合物
EA019060B1 (ru) * 2009-08-03 2013-12-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Способ получения 1-бензил-3-гидроксиметил-1н-индазола и его производных и необходимые промежуточные соединения с магнием
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
US8518945B2 (en) 2010-03-22 2013-08-27 Hoffmann-La Roche Inc. Pyrrolopyrazine kinase inhibitors
US8481541B2 (en) 2010-03-22 2013-07-09 Hoffmann-La Roche Inc. Pyrrolopyrazine kinase inhibitors
EP2571881A1 (de) 2010-05-20 2013-03-27 F.Hoffmann-La Roche Ag Pyrrolopyrazinderivate als syk- und jak-hemmer
MX2012013378A (es) 2010-05-20 2013-01-24 Hoffmann La Roche Derivados de pirrolo [2, 3-b] pirazina-7-carboxamida y sus uso como inhibidores de cinasa janus (jak) y cinasa tirosina del brazo (syk).
JP6644017B2 (ja) * 2017-03-30 2020-02-12 長弘生物科技股▲ふん▼有限公司 ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1046634B1 (de) * 1997-12-27 2003-09-10 Kaneka Corporation Verfahren zur herstellung von beta-halogen-alpha-amino-carbonsäuren, phenylcysteinderivaten und ihren zwischenprodukten
US6887898B1 (en) * 1999-10-22 2005-05-03 Darrick S. H. L. Kim Pharmaceutical compositions useful in prevention and treatment of beta-Amyloid protein-induced disease
US6559174B2 (en) 2001-03-20 2003-05-06 Merck & Co., Inc. N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
US7256186B2 (en) 2002-02-06 2007-08-14 Schering Corporation Gamma secretase inhibitors
US20040171614A1 (en) * 2002-02-06 2004-09-02 Schering-Plough Corporation Novel gamma secretase inhibitors
EP1526852A1 (de) * 2002-07-25 2005-05-04 Pharmacia Italia S.p.A. Bizyklische pyrazole wirksam als kinase inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
US20060264380A1 (en) 2003-07-21 2006-11-23 Mats Hellstrom Compounds and Methods for Promoting Angiogenesis
JP2007506787A (ja) * 2003-09-23 2007-03-22 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼインヒビターとしてのピラゾロピロール誘導体
AU2006279312A1 (en) * 2005-08-19 2007-02-22 Elan Pharmaceuticals, Inc. Bridged N-cyclic sulfonamido inhibitors of gamma secretase
AR057959A1 (es) 2005-12-01 2007-12-26 Elan Pharm Inc 5-pirazolpiperidinas-(sustituidas)
TW200813054A (en) 2006-06-02 2008-03-16 Elan Pharm Inc Fused, tricyclic sulfonamide inhibitors of gamma secretase

Also Published As

Publication number Publication date
AR066712A1 (es) 2009-09-09
ES2373253T3 (es) 2012-02-01
CA2687765A1 (en) 2008-12-04
JP2010528036A (ja) 2010-08-19
EP2152713B1 (de) 2011-09-07
AU2008256940A1 (en) 2008-12-04
BRPI0812014A2 (pt) 2014-11-18
US7977368B2 (en) 2011-07-12
ZA200908919B (en) 2010-08-25
TW200904413A (en) 2009-02-01
MX2009012525A (es) 2009-12-09
CL2008001516A1 (es) 2008-10-10
PE20090280A1 (es) 2009-03-19
WO2008147800A1 (en) 2008-12-04
CO6241122A2 (es) 2011-01-20
US20090099235A1 (en) 2009-04-16
EP2152713A1 (de) 2010-02-17
NZ582039A (en) 2012-02-24

Similar Documents

Publication Publication Date Title
CY2020025I1 (el) Αναστολεις βητα-λακταμασων
ATE543816T1 (de) Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase
EP2192838A4 (de) Heterocyclische nekroptose-hemmer
ATE549340T1 (de) Spiroindolinon-derivate als mdm2-p53 inhibitoren
SMT201600267B (it) Inibitori di syk imidazopirazinici
ATE510825T1 (de) Acylaminopyrazole als fgfr-inhibitoren
ATE551342T1 (de) Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
EP2373163A4 (de) Heterocyclische verbindungen und anwendungsverfahren
ATE478064T1 (de) Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate
ATE523511T1 (de) Pyrazolopyrrolidine als inhibitoren von gamma- sekretase
EP2346508A4 (de) Heterocyclische kinasehemmer
EP2272817A4 (de) Pai-1-hemmer
DK2178888T3 (da) Proteasomhæmmere
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
HRP20190016T1 (hr) Heterociklički spojevi i njihova upotreba
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
BRPI0814256A2 (pt) Inibidores de tetrahidropiranocromeno gama secretase
BRPI0921348A2 (pt) moduladores heterocíclicos da gama secretase
DE112007000789A5 (de) Verwendung von Bora-tetraazepentalenen
ATE493174T1 (de) Verbindungen und zusammensetzungen als kanal- aktivierende proteasehemmer
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
ATE495153T1 (de) Arylsulfonylpyrrolidine als 5-ht6-inhibitoren
EP2124563A4 (de) Benzimidazol-trpv1-hemmer
BRPI0919977A2 (pt) Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmos
ATE461926T1 (de) Substituierte n-arylsulfonylheterocyclische amine als gamma-sekretase-hemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties